Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer.

Neoadjuvant oncological therapy was more common in the β-blocker negative cohort but did not reach statistical significance (66.7% vs. 61.6%, p = 0.05) (Table 2 ).

also in 111,027 other papers